Insider Transactions in Q2 2021 at Therapeutics Md, Inc. (TXMD)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 14
2021
|
Tommy G Thompson Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.7%
|
$5,000
$1.06 P/Share
|
|
May 11
2021
|
Robert G Finizio CEO |
SELL
Open market or private sale
|
Direct |
67,697
-0.37%
|
$67,697
$1.04 P/Share
|
|
May 11
2021
|
John C.K. Iv Milligan Secretary/CEO of subsidiary |
SELL
Open market or private sale
|
Direct |
44,252
-2.46%
|
$44,252
$1.04 P/Share
|
|
May 11
2021
|
Edward Borkowski EVP, Operations |
SELL
Open market or private sale
|
Direct |
44,252
-42.76%
|
$44,252
$1.04 P/Share
|
|
May 11
2021
|
Marlan D Walker Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
21,592
-42.76%
|
$21,592
$1.04 P/Share
|
|
May 11
2021
|
Michael C Donegan Prin. Fin. and Acctg. Officer |
SELL
Open market or private sale
|
Direct |
4,842
-25.48%
|
$4,842
$1.04 P/Share
|
|
May 10
2021
|
Robert G Finizio CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
158,334
+0.87%
|
-
|
|
May 10
2021
|
John C.K. Iv Milligan Secretary/CEO of subsidiary |
BUY
Exercise of conversion of derivative security
|
Direct |
103,500
+5.45%
|
-
|
|
May 10
2021
|
Edward Borkowski EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
103,500
+50.0%
|
-
|
|
May 10
2021
|
Marlan D Walker Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,500
+50.0%
|
-
|
|
May 10
2021
|
Michael C Donegan Prin. Fin. and Acctg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+50.0%
|
-
|